97 related articles for article (PubMed ID: 3262417)
1. Cooperation between early acting delayed-type hypersensitivity T-cells and cultured effector cells in tumor rejection.
Trial J
Cancer Res; 1988 Nov; 48(21):5922-6. PubMed ID: 3262417
[TBL] [Abstract][Full Text] [Related]
2. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
Ptak W; Herzog WR; Askenase PW
J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
Tomita S; Fujiwara H; Yamane Y; Sano S; Nakajima H; Izumi Y; Arai H; Kawanishi Y; Tsuchida T; Hamaoka T
Jpn J Cancer Res; 1986 Feb; 77(2):182-9. PubMed ID: 3082830
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of tolerance induction of tumor-specific delayed-type hypersensitivity responses by intravenous inoculation of tumor cells.
Sato S; Fukuzawa M; Nakajima H; Ogata M; Kosugi A; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1985 Nov; 76(11):1099-106. PubMed ID: 2935516
[TBL] [Abstract][Full Text] [Related]
5. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
Fortner GW; Kripke ML
J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
[TBL] [Abstract][Full Text] [Related]
6. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities.
Van Loveren H; Askenase PW
J Immunol; 1984 Nov; 133(5):2397-401. PubMed ID: 6332849
[TBL] [Abstract][Full Text] [Related]
7. A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors.
Van Loveren H; Den Otter W; Meade R; Terheggen PM; Askenase PW
J Immunol; 1985 Feb; 134(2):1292-9. PubMed ID: 3871209
[TBL] [Abstract][Full Text] [Related]
8. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous immune rejection of intraocular tumors in mice.
Niederkorn JY; Meunier PC
Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):877-84. PubMed ID: 3924853
[TBL] [Abstract][Full Text] [Related]
10. [Effect of radiation on tumor-specific delayed-type hypersensitivity (DTH) response in mice].
Kawahara S; Hashimoto T; Hachisu R
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):675-80. PubMed ID: 2798059
[TBL] [Abstract][Full Text] [Related]
11. The absence of delayed-type hypersensitivity reactivity in a syngeneic murine tumour system.
Los G; De Weger RA; Moberts RM; Van Loveren H; Sakkers RJ; Den Otter W
Immunology; 1987 Sep; 62(1):89-95. PubMed ID: 3498686
[TBL] [Abstract][Full Text] [Related]
12. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen.
Sewell WA; Munoz JJ; Scollay R; Vadas MA
J Immunol; 1984 Oct; 133(4):1716-22. PubMed ID: 6206132
[TBL] [Abstract][Full Text] [Related]
14. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
Bril H; van den Akker TW; Molendijk-Lok BD; Bianchi AT; Benner R
J Immunol; 1984 Feb; 132(2):599-604. PubMed ID: 6228591
[TBL] [Abstract][Full Text] [Related]
15. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
16. Regulation of delayed-type hypersensitivity. VI. Antigen-specific suppressor T cells and suppressor factor for delayed-type hypersensitivity to histocompatibility antigens.
Liew FY
Transplantation; 1982 Jan; 33(1):69-76. PubMed ID: 6461112
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of early and late delayed-type hypersensitivity reactions mediated by human T cells.
Trial J
Reg Immunol; 1989; 2(1):14-21. PubMed ID: 2534946
[TBL] [Abstract][Full Text] [Related]
18. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
Miller SD; Butler LD
J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
[TBL] [Abstract][Full Text] [Related]
19. Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity.
Puccetti P; Bianchi R; Fioretti MC; Ayroldi E; Uyttenhove C; Van Pel A; Boon T; Grohmann U
Eur J Immunol; 1994 Jun; 24(6):1446-52. PubMed ID: 8206103
[TBL] [Abstract][Full Text] [Related]
20. T cell lines active in the delayed-type hypersensitivity reaction (DTH).
Weiss S; Dennert G
J Immunol; 1981 May; 126(5):2031-5. PubMed ID: 6971319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
